Pharma Pulse 11/21/24: New Tricks to Solve Age-Old Problems, Medicare Open Enrollment Attracts Scammers & more

Drilling in on Disease Hallmarks: New Tricks to Solve Age-Old Problems
Ann Beliën, PhD, founder and CEO of Rejuvenate Biomed, discusses how AI is being used to find new ways to treat age-related conditions.

Medicare Open Enrollment Attracts Enrollees and Scammers Alike
Medicare fraud costs Americans about $60 billion each year and healthcare plans are stepping in spread awareness and stop criminals.

Health Care Roundup: Market Talk
European defense and pharmaceutical stocks are expected to perform strongly beyond 2025, Moody’s analysts Martin Kohlhase and Marina Albo say in a note to investors. Europe’s defense companies continue to benefit from structural demand drivers that are unlikely to abate in the next years, they say. Their order books are strong and cover between two and five years of revenue, they write. Global supply-chain challenges affecting aerospace and defense companies pose the main risk to Moody’s double-digit percentage operating profit growth forecast for 2025, they note.

Trump Picks Oz for CMS Administrator
Mehmet Oz, M.D., is another unconventional pick by Trump and is perhaps another an indication that Trump intends to let his HHS secretary nominee, Robert F. Kennedy Jr., "go wild on health."

Tinu Cherian Abraham on LinkedIn

Pharmaceutical Commerce Magazine: "Why Blockchain is Key to Enhancing Supply Chain Integrity"

In a second part of the video interview with Pharma Commerce, Jonathan Colehower, managing director, global operations & supply chain practice at UST, and Editor Nicholas Saraceno, he discussed how the East and Gulf Coast port strikes highlighted the contrasting dynamics between branded and generic pharmaceuticals. Branded drugs, which offer higher profit margins, are produced at limited manufacturing sites, creating potential vulnerabilities. In contrast, generics have multiple supply sources but operate with tighter margins, leading to less robust business controls and raising concerns about safety. This disparity underscores the complex challenges faced by both sectors in the pharmaceutical industry. Colehower also spoke on the valuable in pharma supply chain transparency and visibility.

Watch here for the video and transcript: https://lnkd.in/ggPicUuN

Krishna Sudheendra Manu Gopinath Alexander Varghese Leslie Schultz Vijay Padmanabhan Sunil Balakrishnan Niranjan Ramsunder Tony Velleca Praveen Prabhakaran Sajesh Gopinath Yuval Wollman Colleen Doherty Kavita Kurup Krishna Kishore Ankarboina David Berney Krishna Prasad Youssef Mogadam Vivianne Farmer Vinay Kumar Vijayakumar Neha Misri Merrick Laravea Roshni Das Kailash Attal Kaushal Tripathi

#UST #PublicRelations #MediaRelations #PR #CorporateCommunications

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs